Odyssey Health (ODYY) Net Income towards Common Stockholders (QoQ) (2015 - 2026)
Odyssey Health (ODYY) Net Income towards Common Stockholders (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 228.86% |
| Jan 31, 2026 | -49.14% |
| Oct 31, 2025 | -58.20% |
| Jul 31, 2025 | -0.07% |
| Apr 30, 2025 | -14.36% |
| Jan 31, 2025 | 66.04% |
| Oct 31, 2024 | 94.91% |
| Jul 31, 2024 | -1,412.39% |
| Apr 30, 2024 | -106.37% |
| Jan 31, 2024 | 2,555.70% |
| Oct 31, 2023 | 33.90% |
| Jul 31, 2023 | 36.61% |
| Apr 30, 2023 | 23.19% |
| Jan 31, 2023 | 22.21% |
| Oct 31, 2022 | -82.70% |
| Jul 31, 2022 | 62.05% |
| Apr 30, 2022 | -41.86% |
| Jan 31, 2022 | -32.71% |
| Oct 31, 2021 | 36.14% |
| Jul 31, 2021 | 79.30% |